Welcome to our dedicated page for Yatsen Hldg news (Ticker: YSG), a resource for investors and traders seeking the latest updates and insights on Yatsen Hldg stock.
Yatsen Holding Limited reports on a China-based beauty group that sells color cosmetics, skincare and other cosmetic products through a portfolio of brands. Recurring updates cover financial results for its Skincare Brands and Color Cosmetics Brands, annual Form 20-F reporting, and developments across brands such as Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU's mainland China business and Eve Lom.
Company news also includes product innovation, R&D investment, beauty-science publications, online and offline customer engagement in China, and governance or ADR-related disclosures tied to its NYSE-listed American depositary shares.
Yatsen (NYSE:YSG) reported unaudited Q1 2026 results with total net revenues up 22.5% to RMB1.02 billion, driven by a 58.5% increase in Skincare Brands to RMB574.2 million (56.2% of revenue). Gross margin rose to 80.2%, but net loss widened to RMB61.9 million and non-GAAP results turned to a loss. Operating expenses rose 32.5%, mainly from higher selling and marketing and R&D spending. Cash, restricted cash and short-term investments declined to RMB934.2 million, with RMB90.0 million operating cash outflow. The company completed a first closing of a ~US$120 million private placement of convertible notes and warrants and guided Q2 2026 revenue to RMB1.20–1.30 billion, implying 10%–20% year-over-year growth.
Yatsen (NYSE:YSG) completed the first tranche of its previously announced RMB-denominated convertible senior notes and warrants private placement and confirmed Hillhouse as a co-investor alongside Trustar Capital and founder Jinfeng Huang.
The two equal tranches total approximately US$120 million, funding R&D, supply chain, overseas expansion, M&A and general corporate purposes.
Yatsen (NYSE:YSG) will release unaudited Q1 2026 financial results on May 26, 2026, before U.S. market open.
Management will host a conference call at 7:30 A.M. U.S. Eastern Time (7:30 P.M. Beijing/Hong Kong Time), with live and archived webcast access via the investor relations website.
Yatsen (NYSE:YSG) highlighted that it has invested approximately $100 million (RMB 700 million) in R&D since 2020 as part of a broader industry shift toward technology-led beauty. The company cites a global strategy of three research centers, six joint labs and over 20 collaborations to support brand globalization and product efficacy.
Yatsen also noted Perfect Diary's international traction and a top-selling lipstick SKU recognition, positioning domestic Chinese brands as innovation-driven competitors abroad.
Yatsen (NYSE:YSG) filed its 2025 annual report on Form 20-F with the U.S. SEC on April 29, 2026, covering the fiscal year ended December 31, 2025. The report is available on the company investor relations website and the SEC website, and hard copies are available on request.
Yatsen (NYSE: YSG) agreed to a private placement of RMB-denominated convertible senior notes and warrants totaling about US$120 million in two equal tranches, with participation by Trustar Capital and founder Jinfeng Huang. The First Note targets issuance in or around March 2026; the Second Note later in 2026.
The Notes bear 1.5% annual interest, convert after 364 days at a $4.63 conversion price (20% premium), and include Warrants equal to one-tenth of shares issuable on conversion. Proceeds will fund R&D, supply chain integration, overseas expansion and M&A.
Yatsen (NYSE: YSG) reported fourth-quarter and full-year 2025 results with revenue growth and improved profitability. Total net revenues rose 20.1% Q4 to RMB1.38 billion and 26.7% FY to RMB4.30 billion. Skincare revenues grew 63.5% FY and reached 53.0% of full-year sales. Gross margin improved to 78.2% FY. The company narrowed its full-year net loss to RMB92.4 million and achieved non-GAAP net income RMB8.4 million for 2025. Cash, restricted cash and short-term investments totaled RMB1.05 billion at year-end. Q1 2026 revenue guidance: RMB958.6M–RMB1.08B (≈15%–30% YoY).
Yatsen (NYSE: YSG) will release its unaudited fourth quarter and full year 2025 financial results on March 2, 2026 before U.S. market open. Management will host a conference call the same day to discuss results.
The call is scheduled for 7:30 A.M. ET / 8:30 P.M. Beijing/Hong Kong Time, with live webcast and archived audio available on the company's investor relations website. Telephone and replay access numbers and a replay access code are provided through March 9, 2026.
Yatsen (NYSE:YSG) reported third quarter 2025 unaudited results with total net revenues up 47.5% to RMB998.4 million (US$140.2M) and skincare revenues up 83.2% to RMB490.8 million (US$68.9M), representing 49.2% of revenues. Gross margin rose to 78.2% from 75.9% and gross profit increased 51.9% to RMB780.5 million (US$109.6M). Net loss narrowed by 41.9% to RMB70.4 million (US$9.9M); non-GAAP net loss narrowed 32.8% to RMB51.5 million (US$7.2M). Operating expenses rose 31.9% to RMB864.1 million but fell as a % of revenue to 86.5%. Cash, restricted cash and short-term investments were RMB1.16 billion as of Sept 30, 2025. Q4 2025 revenue guidance: RMB1.32–1.49 billion (approx. +15% to +30% YoY).
Yatsen Group (NYSE: YSG) published Yatsen Group Beauty Innovation Insight on November 13, 2025 — described as China’s first comprehensive white paper on beauty science, sustainability, and corporate responsibility.
The report spans six chapters on global R&D networks, technology breakthroughs, efficacy validation, and sustainable development. Yatsen highlighted 32 peer-reviewed papers since 2022, 252 global patents (including 78 invention applications), participation at major congresses, and a two-year MSCI ESG Rating A.
The Insight emphasizes lab-to-market translation (Biotec™ Technology, ActiveAnchor®) and sustainability steps such as product carbon footprint certification and packaging reductions.